News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fosun Pharma, TPG Scoop Up US-Listed Chinese Healthcare Firm Chindex International, Inc. (CHDX) In $369 Million Deal


2/18/2014 7:17:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd will become the largest shareholder in Chindex International Inc after it and private equity firm TPG said they would take the firm private in a $369 million deal. The deal would give Fosun and TPG access to China's fast-growing private healthcare market, with the government keen to promote investment in the sector to support overburdened public hospitals and bring prices down through increased competition. China's healthcare sector is estimated to hit $1 trillion by 2020, according to McKinsey & Company, but is bogged down by rampant corruption, skills shortages and fragmentation.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Bloomberg
Read at RTT News
Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES